Oculis Holding AG
OCSAW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001953530
No open-market purchases or sales by Oculis Holding AG insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $1.16M in total; no superinvestor holds it.
Other share classesOCS
Q1 2025 vs. Q4 2024
How the institutions holding Oculis Holding AG changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Q1 2025 | Change |
|---|---|---|---|
| Holders | 15 | 12 | −3 |
| Shares | 448.6K | 283.7K | −164.9K (−36.8%) |
| Value | $2.45M | $2.14M | −$309.9K (−12.7%) |
New holders (2)
Institutions that held Oculis Holding AG at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Susquehanna International Group, LLP | 12,007 | $90.6K | 0.00% |
| UBS Group AG | 490 | $3.70K | 0.00% |
Sold out (5)
Institutions that held Oculis Holding AG at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Greenland Capital Management LP | 50,100 | $270.5K |
| Calamos Advisors LLC | 33,333 | $186.7K |
| State of Wisconsin Investment Board | 19,560 | $109.4K |
| Whitebox Advisors LLC | 16,833 | $90.7K |
| Sculptor Capital LP | 14,015 | $78.4K |